Catalyst Wire Dossier Catalyst Wire Dossier

Bromfenac ophthalmic solution, 0.07%

Bromfenac sodium · Apotex Corp.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bromfenac ophthalmic solution, 0.07%, covering 2024-07-08 to 2024-07-08. Get the full timeline:

Most recent: FDA Approved: BROMFENAC OPHTHALMIC SOLUTION, 0.07% — Original Application (Apotex Corp.)

See pricing